Form 8-K

8-K — SPLASH BEVERAGE GROUP, INC.

Accession: 0001731122-26-001114

Filed: 2026-08-20

Period: 2026-08-20

CIK: 0001553788

SIC: 2080 (BEVERAGES)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — e7875_8k.htm (Primary)

EX-99.1 — EXHIBIT 99.1 (e7875_ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: e7875_8k.htm · Sequence: 1

false

0001553788

2026-08-20

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

August 20, 2026

SPLASH

BEVERAGE GROUP, INC.

(Exact name of registrant as specified in its charter)

Nevada

001-40471

34-1720075

(State or other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1112 N. Flagler Drive

Fort Lauderdale, Florida

33304

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area

code: (954) 648-7238

Check the appropriate box below if the Form 8-K filing

is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications

pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant

to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications

pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications

pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an

emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange

Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark

if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards

provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of

the Act:

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

SBEV

NYSE American LLC

Item 2.02. Results of Operations and Financial

Condition.

On August 20, 2026, Splash Beverage Group, Inc. (the

“Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of the

press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Item 2.02, including Exhibit

99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange

Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 2.02

and Exhibit 99.1 shall not be incorporated by reference into any filing under the Securities Act of 1933, or the Exchange Act, except

as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit

Description

99.1

Press Release dated August 20, 2026 (furnished herewith)

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of

the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

SPLASH BEVERAGE GROUP, INC.

Date: August 20, 2026

By:

/s/ Brady Cobb

Name:

Brady Cobb

Title:

Interim Chief Executive Officer

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: e7875_ex99-1.htm · Sequence: 2

EXHIBIT 99.1

Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic

Transformation Toward Endovia Health Sciences

The Company’s loss from continuing operations declined by approximately

64% for the first six months of 2026 as cost reductions take hold

FORT LAUDERDALE, Fla., August 20, 2026 — Splash Beverage Group,

Inc. (NYSE American: SBEV) (“Splash” or the “Company”) today reported financial results for the second quarter

ended June 30, 2026, and provided an update on the Company’s ongoing strategic transformation toward Endovia Health Sciences.

For the six months ended June 30, 2026, the Company’s

loss from continuing operations was approximately $4 million dollars, compared with approximately $11 million dollars for the six months

ended June 30, 2025, representing an improvement of approximately $7 million dollars, or 64%. Management attributes the improvement primarily

to significant cost-reduction initiatives that have been implemented over the past six (6) months as the Company has sought to shift

its business focus and transition from the sale of alcoholic beverages to the development and commercialization of cannabinoid health

and wellness products.

Building the Foundation

During the second quarter, management remained focused on reducing the

Company’s operating cost structure, simplifying the business and strengthening its financial foundation.

Key developments included:

● Reducing loss from continuing operations by approximately 64% year-over-year for the six-month period;

● Continuing to reduce corporate overhead and administrative expenses;

● Simplifying the Company’s operating structure and legacy obligations; and

● Advancing the strategic repositioning of the business toward pharmaceutical, veterinary

and cannabinoid-based health sciences opportunities.

“The first half of 2026 was about rebuilding the foundation of our

Company,” said Brady Cobb, Interim Chief Executive Officer of Splash Beverage Group. “Through disciplined execution and significant

cost reductions, we expect to reduce our loss from continuing operations by approximately 64% compared with the same period last year.

That progress has given us a more efficient operating platform from which to execute the strategic initiatives announced following quarter-end.”

Executing the Transformation

Subsequent to June 30, 2026, the Company executed several strategic initiatives

that management believes materially reposition the business for its next phase of growth.

CannEpil® Licensing

In early July 2026 Splash entered into an exclusive global license for

CannEpil®, a pharmaceutical-grade cannabinoid platform originally developed for drug-resistant epilepsy, providing the Company with

a differentiated pharmaceutical asset and a foundation for future regulated therapeutic opportunities.

Veterinary Expansion

The Company subsequently expanded its CannEpil® license to include veterinary

applications, initially targeting companion-animal oncology and chronic pain management.

Lupvindol Development Collaboration

On July 31, 2026, Splash entered into a development and collaboration agreement

with Lupvindol Biosciences Ltd. Under the agreement, Lupvindol will lead the scientific and FDA regulatory development of a CannEpil-based

veterinary product through the FDA Center for Veterinary Medicine’s Investigational New Animal Drug, or INAD, and Conditional Approval

pathways.

The collaboration is designed to advance product development, required

preclinical and clinical studies, FDA submissions and potential future commercialization and licensing activities.

International Commercialization Efforts

The Company has also initiated preparations to relaunch CannEpil® through

existing commercial and distribution relationships in the United Kingdom, Ireland and select Latin American markets.

Endovia Health Sciences

Splash has announced its intention to rebrand as Endovia Health Sciences,

with a corporate name change and ticker symbol change expected to take effect on the NYSE American beginning on August 24, 2026. The rebranding

reflects the Company’s evolution into a diversified cannabinoid-based health sciences platform focused on pharmaceutical commercialization,

FDA-regulated human and veterinary therapeutics, and cannabinoid consumer wellness and beverage opportunities.

“The actions taken since quarter-end represent the execution phase

of the strategy we spent the first half of the year preparing for,” Cobb continued. “We have added a differentiated pharmaceutical

platform, expanded into FDA-regulated veterinary therapeutics, engaged an experienced cannabinoid drug-development team, begun rebuilding

international commercialization and established a new corporate identity designed to reflect the company we are becoming.”

“Our focus remains straightforward: execute against measurable milestones,

allocate capital responsibly and build a diversified cannabinoid-based health sciences platform capable of creating sustainable long-term value

for our shareholders.”

About Splash Beverage Group, Inc.

Splash Beverage Group, Inc. (NYSE American: SBEV) is transitioning toward

Endovia Health Sciences, a diversified cannabinoid-based health sciences platform focused on acquiring, developing and commercializing

differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets.

Where Science Meets Cannabinoid Innovation

More Information

Splash Beverage Group

Contact Information

Splash Beverage Group

Info@SplashBeverageGroup.com

Media Contact

Angela Gorman

AMWPR

angela@amwpr.com

917-348-0083

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements, including statements

regarding the Company’s new strategic focus, efforts towards the development and commercialization of pharmaceutical products for

humans and animals, anticipated trends and expectations for the Company’s business and industry and goals and expectations with

respect to the Company’s new business strategy.

Forward-looking statements involve risks and uncertainties that could cause actual results

to differ materially, including the Company’s ability to raise the necessary capital to finance the its operations and business

plan, satisfy its contractual obligations including our ability to maintain the license under the license agreement for the CannEpil®

product on which the Company’s initial focus depends and related agreements in connection therewith, our ability to complete required

studies, establish product safety and efficacy, obtain and maintain regulatory authorizations, protect intellectual property and the risk

that competitors market the same or similar products, our commercialization or strategic-partnering arrangements, the risk that the market

or demand for any resulting product we seek to commercialize in the future could be less than expected or projected, our ability to meet

our debt obligations and the negative financial and operational consequences of failing to do so, our ability to comply with NYSE American’s

continued listing standards and the risk that we may be delisted, the possibility that our expectations and perceived benefits with respect

to our business plan and strategic transactions we may pursue prove to be incorrect, and risks with respect to our ability to negotiate

and execute definitive agreements, satisfy closing conditions, or obtain required approvals with respect to any such strategic transaction.

There can be no assurance that the Company’s goals and milestones will be achieved, that the Company or its collaborators will receive

or maintain necessary regulatory authorizations or that any initiative will ultimately generate revenue.

Additional risks are described in the Company’s filings with the

Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025 and the Form S-1 filed

on August 7, 2026, as amended. The Company undertakes no obligation to update forward-looking statements except as required by law.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Aug. 20, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 20, 2026

Entity File Number

001-40471

Entity Registrant Name

SPLASH

BEVERAGE GROUP, INC.

Entity Central Index Key

0001553788

Entity Tax Identification Number

34-1720075

Entity Incorporation, State or Country Code

Entity Address, Address Line One

1112 N. Flagler Drive

Entity Address, City or Town

Fort Lauderdale

Entity Address, State or Province

Entity Address, Postal Zip Code

33304

City Area Code

(954)

Local Phone Number

648-7238

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $0.001 par value

Trading Symbol

SBEV

Security Exchange Name

NYSEAMER

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration